Eli Lilly and Company
LLY
Below: live stock price for Eli Lilly and Company (LLY), a 1-year chart, 8 indicators (RSI, MACD, Bollinger, MA, EMA, Stochastic, ATR, Volume), and a compare mode. Add to your portfolio, star to your watchlist, or set a price alert in one place.
Eli Lilly and Company (LLY) trades at 1,176.1 USD on cryptosrank.
- Prev close
- $1,189.41
- Volume (24h)
- $3.11B
- Market cap
- $1.05T
- Currency
- USD
Score
50/ 100 · Mixed
- Value—
- Quality—
- Momentum—
- Growth—
- Risk—
- Dividend—
- Liquidity—
Composite of public market data. Informational only — not investment advice.
Trend projection
Where the recent trend points if it continues.
- +5 bars
- 1,182.42 +0.54%
- +20 bars
- 1,191.19 +1.28%
- +60 bars
- 1,194.6 +1.57%
- +120 bars
- 1,194.73 +1.58%
Linear-regression continuation — not a prediction, not investment advice. ±1σ ≈ 68% range · ±2σ ≈ 95% range: ±0.0302 USD.
Interpretation
Price sits in the middle of the recent range, trend is sloping upward.
Descriptive observation — not investment advice.
Price report
How this asset has actually moved over the last 251 days.
Where the price sits between the window low and high.
- Volatility (annualised)
- 35.6%
- Max drawdown
- -23.3%
- Below period high
- -9.0%
- Best day
- +10.33%
- Worst day
- -7.79%
- Up days
- 51%
- Current streak
- 4 down
- Typical day swing
- 2.9%
- Volume vs average
- -3%
Spread of returns. Higher means larger swings in both directions.
Worst peak-to-trough fall inside the window.
Current price against the highest point in the window.
Share of days that closed above the one before.
Average high-to-low spread within a single day.
Last 10 days against the whole window.
Descriptive statistics over past prices — not a forecast and not investment advice.
Reference levels
Fibonacci retracements and extensions across the recent range.
Reference only — not investment advice.
These coordinates describe past-trade clustering, not where to buy or sell. Do your own research before any trade.
Levels derived from: 1,292.65 high → 1,053.51 low · 60 bars
- ResistanceFib +161.8% extensionnot reached1,679.58 USD+42.81% from current
- ResistanceFib +100% extensionnot reached1,531.79 USD+30.24% from current
- ResistanceFib +61.8% extensionnot reached1,440.44 USD+22.48% from current
- ResistanceFib +27.2% extensionnot reached1,357.7 USD+15.44% from current
- ResistanceFib 23.6% retracementtested 8×1,236.21 USD+5.11% from current
- ResistanceFib 38.2% retracementtested 15×1,201.3 USD+2.14% from current
- Current1,176.1 USD
- SupportFib 50% midpointNearesttested 16×1,173.08 USD-0.26% from current
- SupportFib 61.8% retracementtested 18×1,144.86 USD-2.66% from current
- SupportFib 78.6% retracementtested 5×1,104.69 USD-6.07% from current
- SupportFib −27.2% extensionnot reached988.4639 USD-15.95% from current
- SupportFib −61.8% extensionnot reached905.7215 USD-22.99% from current
- SupportFib −100% extensionnot reached814.37 USD-30.76% from current
How to read this
We take the highest and lowest price of the last 60 bars and cut the gap between them at the classic Fibonacci ratios (23.6%, 38.2%, 50%, 61.8%, 78.6%), plus extensions beyond both ends.
“Tested N×” counts how many of those 60 bars actually traded through the level. A level price has crossed many times is one the market has repeatedly agreed on; a level at 0 is pure geometry the price has never reached.
This is a map of where trading has already happened — not a forecast and not a signal. Price moves through these levels all the time.
Recent news
- Eli Lilly's Mounjaro Wins FDA Approval to Reduce Cardiovascular Risk in Type 2 DiabetesMT Newswires1h ago
- FDA approves Lilly's Mounjaro (tirzepatide) to reduce cardiovascular risk in adults with type 2 diabetesPR Newswire1h ago
- Can Eli Lilly's Oncology Portfolio Drive Growth Beyond GLP-1 Drugs?Zacks22h ago
- Mounjaro Vs Trulicity: Eli Lilly’s New FDA Win Puts Its Blockbuster Weight-Loss Drug In FocusStocktwits10m ago
- Amgen Stock Signals Its Confidence. The Market Agrees.Trefis12h ago
- FDA Nods Lilly-Roche's Alzheimer's Blood Test: Healthcare ETFs to Track NowZacks22h ago
- U.S. Stocks Rise After Rosy Nvidia ViewThe Wall Street Journal15h ago
- Novo Sends Oral Wegovy Into China's GLP-1 Race Behind LillyGuruFocus.com17h ago
Related
Other assets in this category.
- 8306.TMitsubishi UFJ Financial Group, Inc.3,656 USD+1.33%
- 7203.TToyota Motor Corporation3,130 USD+1.72%
- 9984.TSoftBank Group Corp.5,166 USD-0.65%
- 6758.TSony Group Corporation3,948 USD+2.02%
- 6861.TKeyence Corporation83,300 USD+1.40%
- NVDANVIDIA Corporation227.98 USD+8.74%
- AAPLApple Inc.314.58 USD+0.36%
- GOOGLAlphabet Inc.340.65 USD-0.39%
Live discussion
Sign in to join the discussion.
- No comments yet. Be the first.